UNAUDITED CONSOLIDATED STATEMENTS OF CASH FLOWS (USD $) In Thousands, unless otherwise specified	9 Months Ended
	Sep. 30, 2012	Sep. 30, 2011
Cash flows from operating activities:
Net income (loss)	$ 57,527	$ 1,163
(Loss) income from discontinued operations, net of income taxes	64,448	4,152
Loss from continuing operations, net of income taxes	(6,921)	(2,989)
Adjustments to reconcile net (loss) income to net cash (used in) provided by operating activities:
Depreciation and amortization	6,115	4,764
Amortization of intangibles	2,844	2,496
Amortization of deferred financing costs	662	775
Change in deferred income tax	2,164	199
Compensation under stock-based compensation plans	4,398	3,983
Loss on disposal of fixed assets	60	129
Changes in assets and liabilities, net of acquired business:
Receivables, net of bad debt expense	88,227	(19,127)
Inventory	(17,873)	3,765
Prepaid expenses and other assets	4,822	5,273
Accounts payable	(34,425)	(5,591)
Claims payable	(1,099)	486
Amounts due to plan sponsors	(3,415)	3,162
Accrued expenses and other liabilities	11,352	9,694
Net cash provided by (used in) operating activities from continuing operations	56,911	7,019
Net cash provided by operating activities from discontinued operations	(31,599)	32,393
Net cash provided by operating activities	25,312	39,412
Cash flows from investing activities:
Purchases of property and equipment, net	(5,837)	(4,239)
Cash consideration paid for acquisitions, net of cash acquired	(41,746)	0
Cash consideration paid to DS Pharmacy	(2,935)	(463)
Cash consideration paid for unconsolidated joint ventures, net of cash acquired	(7,827)	0
Net cash used in investing activities from continuing operations	(58,345)	(4,702)
Net cash provided by (used in) investing activities from discontinued operations	161,499	(2,129)
Net cash used in investing activities	103,154	(6,831)
Cash flows from financing activities:
Borrowings on line of credit	1,041,440	1,294,569
Repayments on line of credit	(1,105,262)	(1,325,882)
Repayments of capital leases	(3,210)	(2,568)
Deferred and other financing costs	0	(22)
Net proceeds from exercise of employee stock compensation plans	5,922	1,460
Surrender of stock to satisfy minimum tax withholding	(174)	(138)
Net cash (used in) provided by financing activities	(61,284)	(32,581)
Net change in cash and cash equivalents	67,182	0
Cash and cash equivalents - end of period	0	0
Cash and cash equivalents - end of period	67,182	0
DISCLOSURE OF CASH FLOW INFORMATION:
Cash paid during the period for interest	13,961	15,031
Cash paid during the period for income taxes, net of refunds	1,628	(3,175)
Capital lease obligations incurred to acquire property and equipment	$ 20	$ 5,930